Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques
- 1 August 2001
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 60 (2), 145-150
- https://doi.org/10.1034/j.1399-0004.2001.600209.x
Abstract
Different types of nucleated fetal cells (trophoblasts, erythroblasts, lymphocytes, and granulocytes) have been recovered in maternal peripheral blood. In spite of many attempts to estimate the number of fetal cells in maternal circulation, there is still much controversy concerning this aspect. The numbers obtained vary widely, ranging from 1 nucleated cell per 104 to 1 per 109 nucleated maternal cells. The purpose of our project was to determine the absolute number of all different types of male fetal nucleated cells per unit volume of peripheral maternal blood. Peripheral blood samples were obtained from 12 normal pregnant women known to carry a male fetus between 18 and 22 weeks of pregnancy. Three milliliters (3 ml) of maternal blood has been processed without any enrichment procedures. Fluorescence in situ hybridization (FISH) and primed in situ labeling (PRINS) were performed, and fetal XY cells were identified (among maternal XX cells) and scored by fluorescent microscopy screening. The total number of male fetal nucleated cells per milliliter of maternal blood was consistent in each woman studied and varied from 2 to 6 cells per milliliter within the group of normal pregnancies. The number of fetal cells in maternal blood, at a given period, is reproducible and can therefore be assessed by cytogenetic methods. This confirms the possibility of developing a non-invasive prenatal diagnosis test for aneuploidies. Furthermore, we demonstrate that it is possible to repeatedly identify an extremely small number of fetal cells among millions of maternal cells.Keywords
This publication has 21 references indexed in Scilit:
- Trisomy 8 and monosomy 7 detected in bone marrow using primed in situ labeling, fluorescence in situ hybridization, and conventional cytogenetic analyses.Cancer Genetics and Cytogenetics, 2001
- Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasmaPublished by Wolters Kluwer Health ,2000
- Optimization of the fluorescence in situ hybridization (FISH) technique for high detection efficiency of very small proportions of target interphase nucleiClinical Genetics, 2000
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisAmerican Journal of Human Genetics, 1998
- PCR Quantitation of Fetal Cells in Maternal Blood in Normal and Aneuploid PregnanciesAmerican Journal of Human Genetics, 1997
- Maternal–fetal immunology and autoimmune disease. Is some autoimmune disease auto‐alloimmune or allo‐autoimmune?Arthritis & Rheumatism, 1996
- Maternal origin of nucleated erythrocytes in peripheral venous blood of pregnant womenHuman Genetics, 1995
- Selection of chromosome-specific primers and their use in simple and double PRINS techniques for rapid in situ identification of human chromosomesCytogenetic and Genome Research, 1995
- Circulating ‘trophoblast’ cells in pregnancy have maternal genetic markersPrenatal Diagnosis, 1988
- PRACTICAL AND THEORETICAL IMPLICATIONS OF FETAL/MATERNAL LYMPHOCYTE TRANSFERThe Lancet, 1969